Pfizer Pharmacokinetic Test Studies v2
Paul Jones made this Official Information request to Ministry of Health
The request was refused by Ministry of Health.
From: Paul Jones
Dear Ministry of Health,
Please advise the date the NZ government and its departments received Pharmacokinetic test/study data from Pfizer for the Comirnaty vaccine.
What animals were used in this study?
Yours faithfully,
Paul Jones
From: Medsafe
Dear Paul
In answer to your queries;
Please advise the date the NZ government and its departments received
Pharmacokinetic test/study data from Pfizer for the Comirnaty vaccine.
You can search for when applications were recieved here
- [1]https://www.medsafe.govt.nz/regulatory/D...
[2]Product/Application Search - Medsafe
Revised: 31 May 2019. Medicines Product/Application Search. Note: While
the status of an application may show ‘Evaluation complete’, ‘Granted’ or
‘Information requested’, it may be 1-2 days before an applicant receives
formal notification (and associated documentation) by email.
www.medsafe.govt.nz
What animals were used in this study?
You can view the full animal study data from a link on this page -
[3]https://www.pfizer.com/news/press-releas...
[4]Pfizer and BioNTech Announce Data from Preclinical Studies of
mRNA-based Vaccine Candidate Against COVID-19 | pfpfizeruscom
Immunization of non-human primates (rhesus macaques) with BNT162b2, a
nucleoside-modified messenger RNA (modRNA) candidate that expresses the
SARS-CoV-2 spike glycoprotein, resulted in strong anti-viral effects
against an infectious SARS-CoV-2 challenge BNT162b2 immunization prevented
lung infection in 100% of the SARS-CoV-2 challenged rhesus macaques, with
no viral RNA detected in the lower ...
www.pfizer.com
I hope this answers your queries.
Kind regards
Becci
--------------------------------------------------------------------------
From: COVID-19 Vaccine <[email address]>
Sent: Friday, 9 July 2021 1:42 PM
To: Medsafe <[email address]>
Cc: Ollie Penno <[email address]>; OIA Requests
<[email address]>; Susan Kenyon <[email address]>
Subject: RE: Official Information request - Pfizer Pharmacokinetic Test
Studies v2
Kia Ora Alex,
Vaccine team doesn’t hold information on the below query.
[5]@Medsafe can your team assist with the below query please?
Ngâ mihi,
Zainab Thameem
Coordinator l Business Support l COVID-19 Vaccine and Immunisation
Programme
Manatû Hauora l Ministry of Health
From: OIA Requests <[6][email address]>
Sent: Friday, 9 July 2021 11:56 am
To: COVID-19 Vaccine <[7][email address]>; Ollie Penno
<[8][email address]>
Subject: Fw: Official Information request - Pfizer Pharmacokinetic Test
Studies v2
Kia ora team,
Could someone please respond directly to the question below? It's not an
OIA
Thank you
Alex
------------------------------------------------------------------------
From: Paul Jones <
Sent: Thursday, 8 July 2021 14:20
To: OIA Requests <[9][email address]>
Subject: Official Information request - Pfizer Pharmacokinetic Test
Studies v2
Dear Ministry of Health,
Please advise the date the NZ government and its departments received
Pharmacokinetic test/study data from Pfizer for the Comirnaty vaccine.
What animals were used in this study?
Yours faithfully,
Paul Jones
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[10][FOI #16013 email]
Is [11][Ministry of Health request email] the wrong address for Official Information
requests to Ministry of Health? If so, please contact us using this form:
[12]https://scanmail.trustwave.com/?c=15517&...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[13]https://scanmail.trustwave.com/?c=15517&...
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.
-------------------------------------------------------------------
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. https://www.medsafe.govt.nz/regulatory/D...
2. https://www.medsafe.govt.nz/regulatory/D...
3. https://www.pfizer.com/news/press-releas...
4. https://www.pfizer.com/news/press-releas...
5. mailto:[email address]
6. mailto:[email address]
7. mailto:[email address]
8. mailto:[email address]
9. mailto:[email address]
10. mailto:[FOI #16013 email]
11. mailto:[Ministry of Health request email]
12. https://scanmail.trustwave.com/?c=15517&...
13. https://scanmail.trustwave.com/?c=15517&...
hide quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence